These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 21571347)

  • 21. Spanish cross-cultural adaptation and psychometric properties of the Schizophrenia Quality of Life short-version questionnaire (SQoL18) in 3 middle-income countries: Bolivia, Chile and Peru.
    Caqueo-Urízar A; Boyer L; Boucekine M; Auquier P
    Schizophr Res; 2014 Oct; 159(1):136-43. PubMed ID: 25212841
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Psychometric properties of the Spanish version of the Body Weight, Image and Self-Esteem Evaluation Questionnaire in patients with severe mental disorders.
    Al-Halabi S; Garcia-Portilla MP; Saiz PA; Fonseca E; Bobes-Bascaran MT; Galván G; Iglesias C; Arrojo M; Benabarre A; Goikolea JM; Sanchez E; Sarramea F; Bobes J
    Compr Psychiatry; 2012 Nov; 53(8):1237-42. PubMed ID: 22578984
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Quality of life and therapeutic result in outpatients with schizophrenia under flupenthixol treatment].
    Kühn KU; Quednow BB; Landen H; Riedel M; Thiel M
    Fortschr Neurol Psychiatr; 2004 Jul; 72(7):397-403. PubMed ID: 15252753
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Response and remission of subjective well-being in patients suffering from schizophrenia spectrum disorders.
    Schennach-Wolff R; Seemüller F; Obermeier M; Messer T; Laux G; Pfeiffer H; Naber D; Schmidt LG; Gaebel W; Klosterkötter J; Heuser I; Maier W; Lemke MR; Rüther E; Buchkremer G; Gastpar M; Jäger M; Möller HJ; Riedel M
    Eur Psychiatry; 2011; 26(5):284-92. PubMed ID: 20435447
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Correlation of physician and patient rated quality of life during antipsychotic treatment in outpatients with schizophrenia.
    Wehmeier PM; Kluge M; Schacht A; Helsberg K; Schreiber W
    Schizophr Res; 2007 Mar; 91(1-3):178-86. PubMed ID: 17303388
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of depressive symptoms on subjective well-being: the importance of patient-reported outcomes in schizophrenia.
    Mauriño J; Sanjúan J; Haro JM; Díez T; Ballesteros J
    Patient Prefer Adherence; 2011; 5():471-4. PubMed ID: 22003284
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Spanish lower extremity functional scale: a reliable, valid and responsive questionnaire to assess musculoskeletal disorders in the lower extremity.
    Cruz-Díaz D; Lomas-Vega R; Osuna-Pérez MC; Hita-Contreras F; Fernández ÁD; Martínez-Amat A
    Disabil Rehabil; 2014; 36(23):2005-11. PubMed ID: 24593163
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Subjective Well-Being Under Neuroleptics Scale short form (SWN-K): reliability and validity in an Estonian speaking sample.
    Haring L; Mõttus R; Jaanson P; Pilli R; Mägi K; Maron E
    Ann Gen Psychiatry; 2013 Sep; 12(1):28. PubMed ID: 24025191
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The RSM-scale: a pilot study on a new specific scale for self- and observer-rated quality of life in patients with schizophrenia.
    Riedel M; Spellmann I; Schennach-Wolff R; Obermeier M; Musil R
    Qual Life Res; 2011 Mar; 20(2):263-72. PubMed ID: 20922485
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term patterns of subjective wellbeing in schizophrenia: cluster, predictors of cluster affiliation, and their relation to recovery criteria in 2842 patients followed over 3 years.
    Lambert M; Schimmelmann BG; Schacht A; Karow A; Wagner T; Wehmeier PM; Huber CG; Hundemer HP; Dittmann RW; Naber D
    Schizophr Res; 2009 Feb; 107(2-3):165-72. PubMed ID: 18842393
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adaptation into Spanish of the Clinically Useful Depression Outcome Scale (CUDOS) for assessing major depressive disorder from the patient's perspective.
    Agüera-Ortiz L; Montón C; Cuervo J; Medina E; Díaz-Cuervo H; Maurino J
    Actas Esp Psiquiatr; 2013; 41(5):287-300. PubMed ID: 24096394
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The subjective well-being under neuroleptic scale - short version (SWN-K) and the SF-36 health survey as quality of life measures in patients with schizophrenia.
    Mauriño J; Cordero L; Ballesteros J
    Patient Prefer Adherence; 2012; 6():83-5. PubMed ID: 22298947
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Validation of a European Spanish-version of the University of California performance Skills Assessment (Sp-UPSA) in patients with schizophrenia and bipolar disorder.
    Garcia-Portilla MP; Gomar JJ; Bobes-Bascaran MT; Menendez-Miranda I; Saiz PA; Muñiz J; Arango C; Patterson TL; Harvey PD; Bobes J; Goldberg TE
    Schizophr Res; 2013 Nov; 150(2-3):421-6. PubMed ID: 24055246
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Associations between symptom severity and well-being among Thai patients with schizophrenia: a cross-sectional analytical study.
    Teetharatkul T; Vitayanont A; Liabsuetrakul T; Aunjitsakul W
    BMC Psychiatry; 2021 Jul; 21(1):348. PubMed ID: 34253169
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Constructing an Index for the Subjective Well-being Under Neuroleptics scale (SWN), short form: applying structural equation modeling for testing reliability and validity of the index.
    Schmidt P; Clouth J; Haggenmüller L; Naber D; Reitberger U
    Qual Life Res; 2006 Sep; 15(7):1191-202. PubMed ID: 17004003
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Social and functional capacity of schizophrenia patients: A cross-sectional study.
    Mohr P; Rodriguez M; Bravermanová A; Melicher T; Čeplová Z; Čermák J; Pečeňák J
    Int J Soc Psychiatry; 2014 Jun; 60(4):352-8. PubMed ID: 23775144
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Linguistic adaptation into Spanish and psychometric validation of the ID-Pain questionnaire for the screening of neuropathic pain].
    Gálvez R; Pardo A; Cerón JM; Villasante F; Aranguren JL; Saldaña MT; Navarro A; Ruiz MA; Díaz S; Rejas J
    Med Clin (Barc); 2008 Nov; 131(15):572-8. PubMed ID: 19080838
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment adherence and insight in schizophrenia.
    Bitter I; Fehér L; Tényi T; Czobor P
    Psychiatr Hung; 2015; 30(1):18-26. PubMed ID: 25867885
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association of subjective well-being, symptoms, and side effects with compliance after 12 months of treatment in schizophrenia.
    Karow A; Czekalla J; Dittmann RW; Schacht A; Wagner T; Lambert M; Schimmelmann BG; Naber D
    J Clin Psychiatry; 2007 Jan; 68(1):75-80. PubMed ID: 17284133
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Spanish cultural adaptation and psychometrical validation of the Treatment Benefit Scale (TBS) in the symptomatic treatment of overactive bladder].
    Errando-Smet C; Ruiz MA; Villacampa-Aubá F; Arlandis-Guzmán S; Rejas J; Ruiz L; García-Vargas M
    Med Clin (Barc); 2013 Jan; 140(1):6-13. PubMed ID: 22257604
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.